Medios (ILM1.DE) stock: key figures, P/E, revenue and dividend

Health Care · Germany · ISIN DE000A1MMCC8

Price
11.36 EUR
Market cap
284.53 m EUR
P/E (2025)
18.12
P/S (2025)
0.14
Dividend yield
0.00 %
Net margin
0.72 %
Return on equity (ROE)
2.92 %
Return on assets (ROA)
1.66 %

Medios financials

Fiscal year20242025
Revenue1.88 bn EUR2.08 bn EUR
Gross profit151.00 m EUR91.00 m EUR
Operating income34.33 m EUR43.15 m EUR
EBIT31.00 m EUR41.00 m EUR
Net income12.00 m EUR15.00 m EUR
Diluted EPS – continuing operations0.49 EUR0.63 EUR

Full history since 2000, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Medios

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.